Figure 2
From: Centrilobular emphysema combined with pulmonary fibrosis results in improved survival
Differences in survival based on emphysema score [ES]. Median survival differed among the three groups (P < 0.001, Kruskal-Wallis one-way ANOVA). By Dunn's multiple comparison tests, patients with ES > 2 (n = 28) had a longer survival than patients with ES 0 (n = 48) and patients with 0 < ES ≤ 2 (n = 26) (P < 0.001 and P < 0.01, respectively). (B) Kaplan-Meier survival analyses revealed significantly longer survival in patients with ES > 2 (P = 0.001; log-rank test).